Vardenafil Activity in Lung Fibrosis and In Vitro Synergy with Nintedanib

Idiopathic pulmonary fibrosis (IPF) remains an intractably fatal disorder, despite the recent advent of anti-fibrotic medication. Successful treatment of IPF, like many chronic diseases, may benefit from the concurrent use of multiple agents that exhibit synergistic benefit. In this light, phosphodi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bourne, Michael H., Kottom, Theodore J., Hebrink, Deanne M., Choudhury, Malay, Leof, Edward B., Limper, Andrew H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699915/
https://www.ncbi.nlm.nih.gov/pubmed/34944010
http://dx.doi.org/10.3390/cells10123502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699915/
https://www.ncbi.nlm.nih.gov/pubmed/34944010
http://dx.doi.org/10.3390/cells10123502

Ejemplares similares